Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Mainz Biomed B.V. Ordinary Shares
MYNZ | US
0.81
USD-0.10
-10.84%
MYNZ | US
About Mainz Biomed B.V. Ordinary Shares
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
31/03/2024
As of date
05/03/2026
Close
0.81
Open
0.93
High
0.93
Low
0.79
Mainz Biomed N.V. a molecular genetics cancer diagnostic company develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz Germany.
View LessMYNZ | US
Risk
127.8
Sharpe
-0.94
Luna's Score
45/100
Recommendation
Sell
Luna says (MYNZ | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
124.1%1 month
127.8%3 months
102.0%6 months
86.3%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.04
Debt to equity
2.28
Debt to assets
0.48
Ent. to EBITDA
-2.84
Ent. to rev.
7.80
PEG
-
Other Fundamentals
EBITDA
-26.07M
MarketCap
17.76M
MarketCap(USD)
17.76M
Div. yield
-
Op. margin
-3.07K
Erngs. growth
-
Rev. growth
11.10
Ret. on equity
-303.20
Short ratio
0.99
Short perc.
12.37
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.39
Range1M
0.61
Range3M
1.05
Volumes: Market Activity
Rel. volume
0.33
Price X volume
159.92K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.84 | 12.67 | Cheaper |
| Ent. to Revenue | 7.80 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 2.04 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 102.04 | 59.59 | Riskier |
| Debt to Equity | 2.28 | -14.36 | Expensive |
| Debt to Assets | 0.48 | 0.34 | Expensive |
| Market Cap | 17.76M | 13.71B | Emerging |
